These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36268004)

  • 21. Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron.
    Burkholz S; Rubsamen M; Blankenberg L; Carback RT; Mochly-Rosen D; Harris PE
    Commun Biol; 2023 Mar; 6(1):288. PubMed ID: 36934204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: A propensity score-matched retrospective cohort study.
    Xu X; Wu H; Jin G; Huang J; Li J; Zhou J; Cao M; Sun D; Zhang W; Peng W; Pu Y; Chen C; Sun Y; Yang H; Zhou S; Fang B
    Phytomedicine; 2023 Mar; 111():154665. PubMed ID: 36641977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of reinfection and severity with the predominant BA.5 Omicron subvariant China, from December 2022 to January 2023.
    Cai J; Zhang H; Zhu K; Zhu F; Wang Y; Wang S; Xie F; Zhang M; Rui L; Li S; Lin K; Xue Q; Yuan G; Wang H; Zhang Y; Fu Z; Song J; Zhang Y; Ai J; Zhang W
    Emerg Microbes Infect; 2024 Dec; 13(1):2292071. PubMed ID: 38054806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 Reinfection With Different SARS-CoV-2 Variants in Children, Ohio, United States.
    Wang H; Wright T; Everhart K; Oyeniran SJ; Mejias A; Leber AL
    J Pediatric Infect Dis Soc; 2023 Apr; 12(4):198-204. PubMed ID: 37004190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in northeastern Brazil.
    Freire-Neto FP; Teixeira DG; da Cunha DCS; Morais IC; Tavares CPM; Gurgel GP; Medeiros SDN; Santos DCD; Sales AO; Jeronimo SMB
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010337. PubMed ID: 36191040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant.
    Shete AM; Patil DY; Sahay RR; Sapkal GN; Deshpande GR; Yadav PD
    Hum Vaccin Immunother; 2022 Nov; 18(6):2127289. PubMed ID: 36170667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical effectiveness of REGEN-COV in SARS-CoV-2 infection with Omicron versus Delta variants.
    Gershengorn HB; Patel S; Ferreira T; Das S; Parekh DJ; Shukla B
    PLoS One; 2022; 17(12):e0278770. PubMed ID: 36459537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers.
    Ellingson KD; Hollister J; Porter CJ; Khan SM; Feldstein LR; Naleway AL; Gaglani M; Caban-Martinez AJ; Tyner HL; Lowe AA; Olsho LEW; Meece J; Yoon SK; Mak J; Kuntz JL; Solle NS; Respet K; Baccam Z; Wesley MG; Thiese MS; Yoo YM; Odean MJ; Miiro FN; Pickett SL; Phillips AL; Grant L; Romine JK; Herring MK; Hegmann KT; Lamberte JM; Sokol B; Jovel KS; Thompson MG; Rivers P; Pilishvili T; Lutrick K; Burgess JL; Midgley CM; Fowlkes AL
    Emerg Infect Dis; 2023 Mar; 29(3):599-604. PubMed ID: 36703252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics and risks of the convalescent COVID-19 patients with re-detectable positive RNA test: a 430 patients with Omicron infected cross-sectional survey in Tianjin, China.
    Li T; Han M; Wang J; Zhou C; Mu H
    J Infect Public Health; 2022 Dec; 15(12):1409-1414. PubMed ID: 36395665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of reinfection and disease after SARS-CoV-2 primary infection: Meta-analysis.
    Flacco ME; Acuti Martellucci C; Baccolini V; De Vito C; Renzi E; Villari P; Manzoli L
    Eur J Clin Invest; 2022 Oct; 52(10):e13845. PubMed ID: 35904405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study.
    Monge S; Rojas-Benedicto A; Olmedo C; Mazagatos C; José Sierra M; Limia A; Martín-Merino E; Larrauri A; Hernán MA;
    Lancet Infect Dis; 2022 Sep; 22(9):1313-1320. PubMed ID: 35658998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 omicron variant clearance delayed in breakthrough cases with elevated fasting blood glucose.
    Zhang X; Si G; Lu H; Zhang W; Zheng S; Huang Z; Liu L; Xue Y; Zheng G
    Virol J; 2022 Sep; 19(1):148. PubMed ID: 36100916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis.
    Deng L; Li P; Zhang X; Jiang Q; Turner D; Zhou C; Gao Y; Qian F; Zhang C; Lu H; Zou H; Vermund SH; Qian HZ
    Sci Rep; 2022 Dec; 12(1):20763. PubMed ID: 36456577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of clinical characteristics of patients with different vaccines and underlying diseases infected with novel coronavirus Omicron variant].
    Xu H; Wang J; Gao H; Wang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):571-575. PubMed ID: 35924509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies.
    Nevejan L; Cuypers L; Laenen L; Van Loo L; Vermeulen F; Wollants E; Van Hecke I; Desmet S; Lagrou K; Maes P; André E
    Emerg Infect Dis; 2022 Aug; 28(8):1729-1731. PubMed ID: 35738346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022.
    Bastard J; Taisne B; Figoni J; Mailles A; Durand J; Fayad M; Josset L; Maisa A; van der Werf S; Parent du Châtelet I; Bernard-Stoecklin S
    Euro Surveill; 2022 Mar; 27(13):. PubMed ID: 35362406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of Omicron Variant Reinfection and Reduction of Reinfection Risk After Coronavirus Disease 2019 Vaccination in Children.
    Ikuse T; Aizawa Y; Hasegawa S; Takahashi M; Hayashi T; Kon M; Tamura T; Matsumoto H; Saitoh A
    J Pediatric Infect Dis Soc; 2023 Dec; 12(12):634-637. PubMed ID: 37936292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance.
    Filippatos F; Tatsi EB; Dellis C; Koukou DM; Papagiannopoulos C; Margeli A; Siahanidou T; Kanaka-Gantenbein C; Syriopoulou V; Michos A
    Epidemiol Infect; 2022 Oct; 150():e177. PubMed ID: 36345855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reinfections with Different SARS-CoV-2 Omicron Subvariants, France.
    Nguyen NN; Houhamdi L; Delorme L; Colson P; Gautret P
    Emerg Infect Dis; 2022 Nov; 28(11):2341-2343. PubMed ID: 36150518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Admissions to a large tertiary care hospital and Omicron BA.1 and BA.2 SARS-CoV-2 polymerase chain reaction positivity: primary, contributing, or incidental COVID-19.
    Voor In 't Holt AF; Haanappel CP; Rahamat-Langendoen J; Molenkamp R; van Nood E; van den Toorn LM; Peeters RP; van Rossum AMC; Severin JA
    Int J Infect Dis; 2022 Sep; 122():665-668. PubMed ID: 35842214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.